Answers are grounded in this paper and cite their sources.
Background: Spirometry-based methacholine challenge testing using the provocative dose causing a 20% decline in forced expiratory volume in 1 s (FEV1, PD20) is a reference method for assessing airway hyperresponsiveness. Impulse oscillometry (IOS), performed during tidal breathing, may capture airway mechanical changes not fully reflected by spirometry. We compared FEV1- and IOS-based methacholine responsiveness in a large, real-world adult cohort and examined associations with clinical markers and symptoms. Methods: We analyzed 794 consecutively referred adults undergoing standardized methacholine challenge testing with concurrent spirometry and IOS. IOS positivity was defined as a ≥40% increase in resistance at 5 Hz (ΔR5 ≥ 40%). Agreement between FEV1–PD20 positivity (PD20 ≤ 1440 µg) and IOS positivity was evaluated using cross-classification and Cohen’s κ. Associations between continuous responses were assessed using Pearson and Spearman correlations. The relationship between ΔR5 and the probability of a ≥20% decline in FEV1 was examined using logistic regression. Predictors of ΔR5 were assessed using multivariable linear regression. Symptom severity was recorded immediately post-challenge using a five-point Likert scale and related to physiological responses. Results: FEV1–PD20 classified 37.5% of participants as hyperresponsive, whereas IOS positivity (ΔR5 ≥ 40%) classified 70.6%. Agreement between methods was limited (κ = 0.09; p < 0.01). ΔFEV1 and ΔR5 were weakly correlated (r = −0.287; ρ = −0.306; both p < 0.001; R2 = 0.08). A 20% decline in FEV1 corresponded on average to a 74% increase in R5, whereas ΔR5 ≥ 40% corresponded to an average FEV1 decline of 7.6%. In multivariable models, referral diagnosis group and age independently predicted ΔR5, whereas FeNO and baseline FEV1% predicted did not. Baseline FEV1% predicted modified the ΔFEV1–ΔR5 slope (interaction β = −0.0317; p = 0.0028). Post-challenge symptom (5-point Likert) related to MCT was associated with both ΔFEV1 and IOS responses; ΔFEV1 showed a stronger linear association with symptoms, whereas IOS measures showed larger stepwise differences across symptom categories. Conclusions: IOS identifies a larger, partly distinct subset of methacholine-responsive individuals compared with conventional FEV1–PD20 criteria and detects mechanical changes at lower levels of spirometric impairment. Despite limited concordance, IOS provides complementary physiological and symptom-relevant information when used alongside spirometry. Standardized IOS response definitions and prospective validation are needed to establish clinical utility.
No takes yet. Share an insight, caveat, or question.
Ringbaek et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: